Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
- 21 June 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (13), 6245-6248
- https://doi.org/10.1073/pnas.91.13.6245
Abstract
Echoviruses are human pathogens belonging to the picornavirus family. Decay-accelerating factor (DAF) is a glycosylphosphatidylinositol (GPI)-anchored surface protein that protects cells from lysis by autologous complement. Anti-DAF monoclonal antibodies prevented echovirus 7 attachment to susceptible cells and protected cells from infection. HeLa cells specifically lost the capacity to bind echovirus 7 when treated with phosphatidylinositol-specific phospholipase C, an enzyme that releases GPI-anchored proteins from the cell surface, indicating that the virus receptor, like DAF, is a GPI-anchored protein. Although Chinese hamster ovary cells do not bind echovirus 7, transfectants expressing human DAF bound virus efficiently, and binding was prevented by pretreatment with an anti-DAF monoclonal antibody. Anti-DAF antibodies prevented infection by at least six echovirus serotypes. These results indicate that DAF is the receptor mediating attachment and infection by several echoviruses.Keywords
This publication has 25 references indexed in Scilit:
- Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells.The Journal of Immunology, 1989
- Decay-Accelerating Factor: Biochemistry, Molecular Biology, and FunctionAnnual Review of Immunology, 1989
- Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.Proceedings of the National Academy of Sciences, 1987
- Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.The Journal of Experimental Medicine, 1987
- Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteinsNature, 1987
- Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1985
- Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.Proceedings of the National Academy of Sciences, 1985
- Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.The Journal of Immunology, 1982
- Enhanced Efficiency of Echovirus 6 by a Transferable Factor in Cultured Human Cells.Experimental Biology and Medicine, 1967
- Purification and chemical analysis of the erythrocyte receptor for hemagglutinating enterovirusesVirology, 1964